Assessment of Six Polymorphic Variants as Genetic Risks for Coronary Artery Disease: A Case–Control Study

Background: Coronary artery disease (CAD) is the leading cause of death worldwide. Certain genetic polymorphisms play an important role in this multifactorial disease, being linked with increased risk of early onset CAD. Objective: To assess six genetic polymorphisms and clinical risk factors in rel...

Full description

Saved in:
Bibliographic Details
Main Authors: Bassam Musa Sadik Al-Musawi, Rafah Kamil Obeid Al-Ajeeli
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2025-04-01
Series:Medical Journal of Babylon
Subjects:
Online Access:https://doi.org/10.4103/MJBL.MJBL_1389_23
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849412857564758016
author Bassam Musa Sadik Al-Musawi
Rafah Kamil Obeid Al-Ajeeli
author_facet Bassam Musa Sadik Al-Musawi
Rafah Kamil Obeid Al-Ajeeli
author_sort Bassam Musa Sadik Al-Musawi
collection DOAJ
description Background: Coronary artery disease (CAD) is the leading cause of death worldwide. Certain genetic polymorphisms play an important role in this multifactorial disease, being linked with increased risk of early onset CAD. Objective: To assess six genetic polymorphisms and clinical risk factors in relation to early onset nondiabetic Iraqi Arab CAD patients compared to controls. Materials and Methods: This case–control study recruited 40 Iraqi patients with early onset CAD and 20 healthy controls. Demographic and clinical data were reported. Six genetic variants were tested: β-fibrinogen (FGB), human platelet antigen 1 (HPA1a/b), angiotensin-converting enzyme (ACE), two variants of endothelial nitric oxide synthase (eNOS), and lymphotoxin alpha (LTA), utilizing a ready-to-use kit. Results: The majority of patients were older males (85%), nonsmokers (52.5%), hypertensives (57.5%), had dyslipidemia (100%), and had a family history of ischemia (77.5%). This contrasts the findings in the control group (P < 0.001). From the six studied polymorphisms, a statistically significant difference was found between patients and controls in relation to ACE and LTA genes (P = 0.032 and 0.028), respectively. None (0%) of the participants had a genetic risk score >6. There was a statistically significant association between higher clinical risk scores and CAD group; eNOS G894T was found to be linked with increasing age, while LTA was linked to dyslipidemia. Conclusions: This study aids in CAD risk stratification. There is a need for longitudinal studies assessing more genetic risks to CAD as a national CAD preventive program for high-risk Iraqi people.
format Article
id doaj-art-e6ebe9b7a6c144699bc4537d25e65296
institution Kabale University
issn 1812-156X
2312-6760
language English
publishDate 2025-04-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Medical Journal of Babylon
spelling doaj-art-e6ebe9b7a6c144699bc4537d25e652962025-08-20T03:34:18ZengWolters Kluwer Medknow PublicationsMedical Journal of Babylon1812-156X2312-67602025-04-0122245846610.4103/MJBL.MJBL_1389_23Assessment of Six Polymorphic Variants as Genetic Risks for Coronary Artery Disease: A Case–Control StudyBassam Musa Sadik Al-MusawiRafah Kamil Obeid Al-AjeeliBackground: Coronary artery disease (CAD) is the leading cause of death worldwide. Certain genetic polymorphisms play an important role in this multifactorial disease, being linked with increased risk of early onset CAD. Objective: To assess six genetic polymorphisms and clinical risk factors in relation to early onset nondiabetic Iraqi Arab CAD patients compared to controls. Materials and Methods: This case–control study recruited 40 Iraqi patients with early onset CAD and 20 healthy controls. Demographic and clinical data were reported. Six genetic variants were tested: β-fibrinogen (FGB), human platelet antigen 1 (HPA1a/b), angiotensin-converting enzyme (ACE), two variants of endothelial nitric oxide synthase (eNOS), and lymphotoxin alpha (LTA), utilizing a ready-to-use kit. Results: The majority of patients were older males (85%), nonsmokers (52.5%), hypertensives (57.5%), had dyslipidemia (100%), and had a family history of ischemia (77.5%). This contrasts the findings in the control group (P < 0.001). From the six studied polymorphisms, a statistically significant difference was found between patients and controls in relation to ACE and LTA genes (P = 0.032 and 0.028), respectively. None (0%) of the participants had a genetic risk score >6. There was a statistically significant association between higher clinical risk scores and CAD group; eNOS G894T was found to be linked with increasing age, while LTA was linked to dyslipidemia. Conclusions: This study aids in CAD risk stratification. There is a need for longitudinal studies assessing more genetic risks to CAD as a national CAD preventive program for high-risk Iraqi people.https://doi.org/10.4103/MJBL.MJBL_1389_23acecadhypertensionihdiraqltapolymorphism
spellingShingle Bassam Musa Sadik Al-Musawi
Rafah Kamil Obeid Al-Ajeeli
Assessment of Six Polymorphic Variants as Genetic Risks for Coronary Artery Disease: A Case–Control Study
Medical Journal of Babylon
ace
cad
hypertension
ihd
iraq
lta
polymorphism
title Assessment of Six Polymorphic Variants as Genetic Risks for Coronary Artery Disease: A Case–Control Study
title_full Assessment of Six Polymorphic Variants as Genetic Risks for Coronary Artery Disease: A Case–Control Study
title_fullStr Assessment of Six Polymorphic Variants as Genetic Risks for Coronary Artery Disease: A Case–Control Study
title_full_unstemmed Assessment of Six Polymorphic Variants as Genetic Risks for Coronary Artery Disease: A Case–Control Study
title_short Assessment of Six Polymorphic Variants as Genetic Risks for Coronary Artery Disease: A Case–Control Study
title_sort assessment of six polymorphic variants as genetic risks for coronary artery disease a case control study
topic ace
cad
hypertension
ihd
iraq
lta
polymorphism
url https://doi.org/10.4103/MJBL.MJBL_1389_23
work_keys_str_mv AT bassammusasadikalmusawi assessmentofsixpolymorphicvariantsasgeneticrisksforcoronaryarterydiseaseacasecontrolstudy
AT rafahkamilobeidalajeeli assessmentofsixpolymorphicvariantsasgeneticrisksforcoronaryarterydiseaseacasecontrolstudy